Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nature Reviews Drug Discovery is Scopus-indexed (Q1, CiteScore 159.2), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Nature Research.
Checked against the index lists dated .
ISSN 1474-1776Verify ISSN ↗1474-1784Verify ISSN ↗
Publisher: Nature Research
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmacology | 1 / 328 | 99th | Q1 |
| Drug Discovery | 1 / 161 | 99th | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2002–present, best quartile Q1, CiteScore 159.2.
Nature Reviews Drug Discovery is Q1 in Pharmacology (rank 1 of 328) and Q1 in Drug Discovery (rank 1 of 161), by CiteScore 2025.
Nature Reviews Drug Discovery is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 159.2, which places it in quartile Q1 at the 99th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 32.577, quartile Q1, with an H-index of 428.
Nature Reviews Drug Discovery is published by Nature Research. Its print ISSN is 1474-1776 and its online ISSN is 1474-1784.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nature Reviews Drug Discovery has an h-index of 483 and a 2-year mean of 14.7 citations per paper (OpenAlex). Its Scopus CiteScore is 159.2, quartile Q1. On 2-year citations it ranks #3 of 319 Scopus journals in Pharmacology.
Nature Reviews Drug Discovery published 241 papers in 2025; its busiest recent year was 2017 with 283. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 35 research articles (2026), authors are most often from United States (26.6%), United Kingdom (17.3%) and China (11.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.